|
|
DSpace at RU >
Browsing by Author Wit, F.W.
Showing results 2 to 9 of 9
| Full Text | Issue Date | Title | Author(s) | | 2009 | Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations | Luin, M. van; Gras, L.; Richter, C., et al |
| 2007 | Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in Thai HIV-1 infected patients. | Autar, R.S.; Wit, F.W.; Sankote, J., et al |
| 2010 | Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavir. | Luin, M. van; Ende, M.E. van der; Richter, C., et al |
| 2004 | Nelfinavir plasma concentrations are low during pregnancy. | Nellen, J.F.; Schillevoort, I.; Wit, F.W., et al |
| 2005 | Nevirapine plasma concentrations and concomitant use of rifampin in patients coinfected with HIV-1 and tuberculosis. | Autar, S.R.; Wit, F.W.; Sankote, J., et al |
| 2007 | Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimen. | Autar, R.S.; Boyd, M.A.; Wit, F.W., et al |
| 2009 | Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. | Kesselring, A.M.; Wit, F.W.; Sabin, C.A., et al |
| 2008 | Steady-state nevirapine plasma concentrations are influenced by pregnancy. | Nellen, J.F.; Damming, M.; Godfried, M.H., et al |
Showing results 2 to 9 of 9
|